Impairment of endothelial and subendothelial sites by a circulating plasma factor associated with minimal change disease

Nephrology Dialysis Transplantation

Volumn 11, Issue 11, 1996, Pages 2185-2191

  Cheung, P K ^a   Baller, J F W ^a   Bakker, W W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Anionic sites; Endothelium; Minimal change disease; Plasma factor

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALBUMIN; HORSERADISH PEROXIDASE; PLASMA PROTEIN; SIALOGLYCOPROTEIN;

ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GLOMERULUS CAPILLARY; HISTOCHEMISTRY; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MINIMAL CHANGE GLOMERULONEPHRITIS; MONOLAYER CULTURE; NONHUMAN; PLASMA FACTOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; VASCULAR ENDOTHELIUM;

EID: 0029944950     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027135     Document Type: Article

References (39)

1. Mallick NP. Epidemiology and natural course of idiopathic nephrotic syndrome. Clin Nephrol 1991; 35 [Suppl 1]: S3-S7
2. Spargo BH, Taylor JR. The kidney. In: Rubin E, Farber JL, eds. Pathology. JB Lippincott Co, Philadelphia, 1988; 832-890
3. Shaloub RJ. Pathogenesis of lipoid nephrosis: A disorder of T-cell function. Lancet 1974; 2: 556-559
4. Schnaper HW, Robson AM. Nephrotic syndrome: minimal change disease, focal glomerulosclerosis and related disorders. In: Schrier RW, Gottschalk CM, eds. Diseases of the Kidney. Little, Brown, Boston, 1993, 1731-1733
5. Melvin T, Bennett W. Management of nephrotic syndrome in childhood. Drugs 1991; 42: 30-51
6. Schena FP, Cameron JS. Treatment of proteinuric idiopathic glomerulonephritides in adults: a retrospective survey. Am J Med 1988; 85: 315-326
7. Hoyer JR, Vernier RL, Najarian JS, Raij L, Simmons RL, Michael AF. Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 1972; 773: 343-348
8. Tomizawa S, Fujisaki M, Kobayashi M, Igarashi M, Narita M. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 1991; 40: 453-460
9. Boulton-Jones JM, Tullock I, Dore B, Mclay A. Changes in the glomerular capillary wall induced by lymphocyte products and serum of nephrotic patients. Clin Nephrol 1983; 20: 72-77
10. Garin EH, Blanchard DK, Matsushima K, Djeu JY. IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int 1994; 45: 1311-1317
11. Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 1991; 40: 453-460
12. Bakker WW. Beukhof JR, van Luijk WHJ, van der Hem GK. Vascular permeability increasing factor (VPF) in IgA nephropathy. Clin Nephrol 1982; 18: 165-267
13. Dantal J, Bigot E, Bogers W et al. Effect of plasma protein absorption on protein excretion in kidney transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994; 330: 7-14
14. Savin VJ. Mechanisms of proteinuria in noninflammatory glomerular diseases. Am J Kidney Dis 1993; 21: 347-362
15. Bakker WW, Baller JFW, van Luijk WHJ. A kallikrein-like molecule and plasma vasoactivity in minimal change disease. Contrib Nephrol 1988; 67: 31-36
16. Cheung PK, Boes A, Bakker WW. Changes in the glomerular filtration barrier induced by contact between a human plasma factor and kidney tissue. Kidney Int 1994; 43: 1462 (abstract)
17. Cheung PK, Klok PA, Bakker WW. Minimal change-like glomerular alterations induced by a human plasma factor. Nephron 1996; 74: 586-593
18. Cheung PK, Boes A, Dijkhuis FWJ, Klok PA, Bakker WW. Minimal change-like alterations of the rat kidney induced by a vasoactive human plasma factor. J Am Soc Nephrol 1994; 5: 940 (abstract)
19. Kitano Y, Yoshikawa N, Nakamura H. Glomerular anionic sites in minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Clin Nephrol 1993; 40: 199-204
20. Stow JL, Sawada H, Farquhar MG. Basement membrane heparan sulphate proteoglycans are concentrated in the laminae rarae and in podocytes of the rat renal glomerulus. Proc Natl Acad Sci USA 1985; 82: 3296-3300
21. Vernier RL. Primary (idiopathic) nephrotic syndrome. In: Holliday MA, Barratt TM, Vernier RL, eds. Pediatric Nephrology. Williams & Wilkins, Baltimore. 1987; 445-456
22. Bakker WW, Roskam G, Hardonk MJ, Vos JTWM, Bleumink E. The glomerular polyanion (GPA) of the rat kidney. III. Further characterization of a vaso-active serum factor which reduces GPA. Br J Exp Pathol 1985; 66: 47-55
23. Langeler EG, van Hinsbergh VWM. Characterization of an in vitro model to study the permeability of human arterial endothelial cell monolayers. Thromb Haemost 1988; 60: 240-246
24. Cheung PK, Visser J, Bakker WW. Upregulation of antithrombotic ectonucleotidases by aspirin in human endothelial cells in vitro. J Pharm Pharmacol 1994; 46: 1032-1034
25. Poelstra K, Hardonk MJ, Koudstaal J, Bakker WW. Intraglomerular platelet aggregation and experimental glomerulonephritis. Kidney Int 1990; 37: 1500-1508
26. Baller JFW, Poelstra K, Hardonk MJ, Bakker WW. A modified cerium-based histochemical method for detection of experimentally-induced ATPase impairment in glomeruli of the rat kidney. J Histochem Cytochem 1993; 41: 1105-1109
27. Hoyer JR, Mauer SM, Michael MF. Unilateral renal disease in the rat I. Clinical, morphological and glomerular functional features of the experimental model produced by renal perfusion with aminonucleoside. J Lab Clin Med 1975; 85: 756-768
28. Schurer JW, Kalicharan D, Hoedemaeker J, Molenaar I. The use of polyethyleneimine for demonstration of anionic sites in basement membranes and collagen fibrils. J Histochem Cytochem 1978; 26: 688-689
29. Vernier RL, Klein DJ, Sisson SP, Mahan JD, Oegema TR, Brown DM. Heparan sulphate-rich anionic sites in the human glomerular basement membrane N Engl J Med 1983; 309: 1001-1009
30. van Setten P, van Hinsbergh VWM, van der Velden T et al. Isolation, purification and characterization of human glomerular microvascular endothelial cells (GMVEC) and the effects of verocytotoxin-1 (VT-1) on (GMVEC). Kidney Int (abstract) 1996; 50: 335-336
31. Wilkinson AH, Gillespie C. Hartley B, Williams DG. Increase in proteinuria and reduction in number of anionic sties on the glomerular basement membrane in rabbits by infusion of human nephrotic plasma in vivo, Clin Sci 1989; 77: 43-48
32. Tanaka R, Yoshikawa N, Nakamura H, Ito H. Infusion of peripheral blood mononuclear cell products from nephrotic children increases albuminuria in rats. Nephron 1992; 60: 35-41
33. Bakker WW, van der Laan SM, Vos JTWM, Hoedemaeker PJ. The glomerular polyanion (GPA) of the rat kidney. I.Concanavalin-A-activated cells affect the glomerular polyanion in vitro. Nephron 1982; 31: 68-74
34. Savage COS. The biology of the glomerulus: endothelial cells. Kidney Int 1994; 45: 314-319
35. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989; 1: 461-463
36. Stewart RJ, Marsden PA. Vascular endothelial cell activation in models of vascular and glomerular injury. Kidney Int 1994; 45 [Suppl 45]: S37-S44
37. Marsen TA, Schramek H, Dunn MJ. Renal actions of endothelin: Linking cellular signaling pathways to kidney disease. Kidney Int 1994; 45: 336-344
38. Yoshimura A, Ideura T, Iwasaki S, Koshikawa S. Aggravation of minimal change nephrotic syndrome by administration of human albumin. Clin Nephrol 1992; 37: 109-114
39. Remuzzi G, Bertani T. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990; 38: 384-394